Does planning out for the next year’s business strategy mean anything to pharmaceutical companies in this cloudy environment?

‘Does it really mean anything?’

As the end of the year has come closer, pharmaceutical companies have got into planning out business strategies for the next year, but have suffered guiding its directions.

Since frequently changing drug prices and policies of the government create the uncertain pharmaceutical environment and issues related to rebates will soon cause controversy in the industry...